Vaccine News and Research

Latest Vaccine News and Research

ID Biomedical announces strategic alliances for U.S. marketing and distribution of Fluviral vaccine

ID Biomedical Corporation announced today that it has signed long term marketing, distribution and minimum purchase agreements with three of the largest influenza vaccine wholesalers in the United States: Henry Schein, Inc.; AmerisourceBergen Corporation's Specialty Group; and McKesson Corporation.

6 Dec 2004

Alliance to develop and commercialize fully-human anti-anthrax antibody

MDX-1303 was developed by Medarex using its UltiMAb Human Antibody Development System, and this antibody is currently in preclinical development by Medarex for use against human anthrax infection.

6 Dec 2004

Canadian experts gather to address emerging issues in immunization

More than 800 physicians, nurses, public health experts and researchers are gathering in Montreal this week for the sixth Canadian Immunization Conference, running Dec. 5-8, 2004. The conference is being hosted by the Public Health Agency of Canada and the Canadian Paediatric Society.

6 Dec 2004

Australian Government's decision to purchase sufficient influenza vaccine for the next three seasons is good health planning

Australian Medical Association Vice President, Dr Mukesh Haikerwal, has said the Australian Government's decision to purchase sufficient influenza vaccine for the next three seasons is good health planning.

6 Dec 2004

New technologies boost immunisation rates, safety

As global health leaders struggle to meet the United Nations goal of reducing mortality among the world's poorest children, vaccines are attracting more and more attention. The purchase of the vaccine is just the beginning, however, as the effectiveness of a vaccine is only as good as its delivery system.

6 Dec 2004

Pennsylvania confirms first influenza case

Pennsylvania Health Secretary Dr. Calvin B. Johnson has announced that a 13-year-old Philadelphia County teen has the season's first, lab-confirmed case of flu.

4 Dec 2004

Animal model helps explain how AIDS virus spreads throughout the body following oral exposure

Researchers at UT Southwestern Medical Center at Dallas have utilized an animal model to trace how the virus that causes AIDS in humans may enter and spread throughout the body following an oral exposure.

3 Dec 2004

Why our immune system worsens with age

Scientists at the Vaccine and Gene Therapy Institute at Oregon Health & Science University have made a discovery that helps explain why our immune system worsens with age. The work was led by Janko Nikolich-Zugich, M.D., Ph.D., a senior scientist at the VGTI.

2 Dec 2004

Potential vaccine for the deadly toxin ricin

A potential vaccine for the deadly toxin ricin, a "Category B" biological agent, will enter the first phase of clinical testing in coming weeks at UT Southwestern Medical Center at Dallas.

30 Nov 2004

Type 1 diabetes could be prevented by a new nasal insulin vaccine

A world-leading medical trial conducted in Melbourne suggests that the onset of type 1 diabetes could be prevented in many at-risk people by a new nasal insulin vaccine.

29 Nov 2004

Joint collaboration to fight avian influenza

Recognizing the pandemic potential and the threat to public health posed by the Avian Influenza, Health Ministers and senior officials of thirteen countries from Southeast and East Asian countries have pledged to accelerate joint collaboration in fighting the disease.

29 Nov 2004

Gillain-Barre syndrome following influenza vaccination has decreased over the past 12 years

The number of reported cases of Gillain-Barre syndrome (a rare paralytic disorder) that occur following influenza vaccination has decreased over the past 12 years, according to a study in the November 24 issue of JAMA.

24 Nov 2004

Researchers recommend vaccinating adolescents against whooping cough

Experts are recommending that adolescents and some adults be vaccinated against whooping cough to help prevent infection and potential transmission to infants, according to the December 15 issue of Clinical Infectious Diseases, now available online.

23 Nov 2004

Women now making up nearly half of the 37.2 million adults (aged 15-49) living with HIV worldwide

A new report released today shows that the number of women living with HIV has risen in each region of the world over the past two years, with the steepest increases in East Asia, followed by Eastern Europe and Central Asia. In East Asia, there was a 56% increase over the past two years, followed by Eastern Europe and Central Asia with 48%.

23 Nov 2004

$10.4 million to provide support for HIV/AIDS research in Peru, Thailand, Cambodia and Russia

HHS Secretary Tommy G. Thompson has announced four new grants totaling $10.4 million to provide support for HIV/AIDS research in Peru, Thailand, Cambodia and Russia, four nations that have been hard hit by the AIDS epidemic.

19 Nov 2004

FDA Vioxx fiasco raises questions about AIDS drug approvals for developing world

AIDS Healthcare Foundation (AHF), today noted that the current "FDA fiasco" involving the agency's initial approval and subsequent recall of Merck's troubled arthritis drug, Vioxx, raises serious questions about the FDA's ongoing parallel role in the approval of generic AIDS drugs for widespread use in Africa and the developing world.

19 Nov 2004

Animal research and its benefits to both humans and animals

From preventing polio to finding cures for cancer patients, animal research has saved countless lives.

18 Nov 2004

Computerized reminder systems increase influenza and pneumococcal vaccination rates

Computer-based standing orders are more effective than computerized reminders to physicians in increasing influenza and pneumococcal vaccine administration for hospitalized patients, according to an article in the November 17 issue of JAMA.

17 Nov 2004

Vaccine provides new hope to the millions of people who suffer from food allergies

A team led by a researcher at the Stanford University School of Medicine has developed vaccines that vastly reduce or eliminate dogs' allergic reactions to three major food allergens: peanuts, milk and wheat. The vaccines' benefits lasted at least three months.

14 Nov 2004

Hearing set to determine if the U.S. will be better prepared for next year’s flu season

U.S. Senator Larry Craig Larry Craig has announced today that the U.S. Senate Special Committee on Aging will hold a hearing on Tuesday, November 16, 2004 at 2:30 p.m. titled “Liability, Licensing and the Flu Vaccine Market: Making Decisions Today to Prevent a Crisis Tomorrow.” It will be held in room 562.

14 Nov 2004

Vaccine News and Research

Latest Vaccine News and Research

ID Biomedical announces strategic alliances for U.S. marketing and distribution of Fluviral vaccine

Alliance to develop and commercialize fully-human anti-anthrax antibody

Canadian experts gather to address emerging issues in immunization

Australian Government's decision to purchase sufficient influenza vaccine for the next three seasons is good health planning

New technologies boost immunisation rates, safety

Pennsylvania confirms first influenza case

Animal model helps explain how AIDS virus spreads throughout the body following oral exposure

Why our immune system worsens with age

Potential vaccine for the deadly toxin ricin

Type 1 diabetes could be prevented by a new nasal insulin vaccine

Joint collaboration to fight avian influenza

Gillain-Barre syndrome following influenza vaccination has decreased over the past 12 years

Researchers recommend vaccinating adolescents against whooping cough

Women now making up nearly half of the 37.2 million adults (aged 15-49) living with HIV worldwide

$10.4 million to provide support for HIV/AIDS research in Peru, Thailand, Cambodia and Russia

FDA Vioxx fiasco raises questions about AIDS drug approvals for developing world

Animal research and its benefits to both humans and animals

Computerized reminder systems increase influenza and pneumococcal vaccination rates

Vaccine provides new hope to the millions of people who suffer from food allergies

Hearing set to determine if the U.S. will be better prepared for next year’s flu season

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Vaccine News and Research

Latest Vaccine News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in